AQR Capital Management
HLVX

AQR Capital Management’s HilleVax HLVX Stock Holding History

AQR Capital Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,219
Closed -$86K – 3517
2025
Q2 		$86K Buy
43,219
+9,724
+29% +$17.8K ﹤0.01% 3203
2025
Q1 		$48.6K Buy
33,495
+9,228
+38% +$17.1K ﹤0.01% 3083
2024
Q4 		$50.2K Buy
+24,267
New +$45.6K ﹤0.01% 2805

AQR Capital Management's HLVX Position: Q3 2025 in Review

AQR Capital Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 43,219 shares — an estimated $86K sold.

AQR Capital Management first reported a position in HLVX in Q4 2024 and held it in 3 quarters. The position peaked at $86K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • AQR Capital Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 43,219 HilleVax shares in Q3 2025, an estimated $86K.
  • AQR Capital Management first reported a position in HilleVax in Q4 2024 and held it in 3 quarters.
  • AQR Capital Management's HilleVax position peaked at $86K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.